Canton Hathaway’s Biohaven BHVN Stock Holding History

Canton Hathaway’s Portfolio BHVN Stock Details BHVN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$190K	Hold	22,500	–	–	0.04%	131
2025 Q4	$254K	Sell	22,500 -3,900	-15%	-$48.3K	0.05%	122
2025 Q3	$396K	Sell	26,400 -4,100	-13%	-$59.7K	0.08%	112
2025 Q2	$430K	Buy	30,500 +9,150	+43%	+$163K	0.09%	104
2025 Q1	$513K	Hold	21,350	–	–	0.1%	81
2024 Q4	$797K	Hold	21,350	–	–	0.2%	51
2024 Q3	$1.07M	Sell	21,350 -500	-2%	-$19.5K	0.27%	44
2024 Q2	$758K	Buy	21,850 +500	+2%	+$19.8K	0.21%	51
2024 Q1	$1.17M	Hold	21,350	–	–	0.31%	39
2023 Q4	$914K	Sell	21,350 -500	-2%	-$15.6K	0.28%	41
2023 Q3	$568K	Buy	21,850 +500	+2%	+$10.4K	0.18%	49
2023 Q2	$511K	Sell	21,350 -1,300	-6%	-$22.4K	0.16%	56
2023 Q1	$309K	Buy	22,650 +5,050	+29%	+$80.4K	0.11%	68
2022 Q4	$244K	Buy	17,600 +13,508	+330%	+$191K	0.08%	82
2022 Q3	$605K	Buy	+4,092	New	+$29.7K	0.22%	54

Other funds holding BHVN

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IAM

Infinitum Asset Management Fort Lauderdale, Florida $801M AUM 8.83% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $173M AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Canton Hathaway's BHVN Position: Q1 2026 in Review

Canton Hathaway held its Biohaven (BHVN) position steady in Q1 2026 at 22,500 shares worth $190K. The position accounts for 0.04% of the portfolio, ranked #131.

Canton Hathaway first reported a position in BHVN in Q3 2022 and has held it in 15 quarters since. The position peaked at $1.17M in Q1 2024. 275 funds tracked by Wall St. Rank hold BHVN as of Q1 2026.

Canton Hathaway held 22,500 shares of Biohaven worth $190K as of Q1 2026.
Canton Hathaway left its Biohaven share count unchanged in Q1 2026.
Biohaven made up 0.04% of Canton Hathaway's portfolio in Q1 2026, its #131 holding.
Canton Hathaway first reported a position in Biohaven in Q3 2022 and has held it in 15 quarters since.
Canton Hathaway's Biohaven position peaked at $1.17M in Q1 2024.
275 funds tracked by Wall St. Rank held Biohaven as of Q1 2026.

Based on Canton Hathaway's 13F filing for Q1 2026, filed 24 Apr 2026.